Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Atossa Genetics Inc
ATOSCurrent price
0.87 USD
-0.065 USD (-6.90%)
Last closed
0.92 USD
Company
www.atossatherapeutics.com
ISIN
US04962H5063
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
134 607 072 USD
Yield for 12 month
+2.21 %
1Y
3Y
5Y
10Y
15Y
ATOS
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington. Address: 107 Spring Street, Seattle, WA, United States, 98104
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6.00 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-23 000 USD
Last Year
-8 000 USD
Current Quarter
–
Last Quarter
-4 000 USD
Key Figures ATOS
1 year
3 years
5 years
10 years
EBITDA
-29 462 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-20.35 %
PEG Ratio
–
Return On Equity TTM
-31.30 %
Wall Street Target Price
6.00 USD
Revenue TTM
–
Book Value
0.59 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.21 USD
Diluted Eps TTM
-0.21 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ATOS
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History ATOS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:12
Payout Ratio
–
Last Split Date
20.04.2018
Dividend Date
20.04.2018
Stock Valuation ATOS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
2.01
Price Book MRQ
1.91
Financials ATOS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ATOS
For 52 weeks
0.71 USD
2.31 USD
50 Day MA
1.36 USD
Shares Short Prior Month
12 454 496
200 Day MA
1.40 USD
Short Ratio
14.73
Shares Short
11 603 127
Short Percent
9.23 %
BeatStart